Scholars Central

Conference abstract

Superior neuro-protective effects of TiO2 nano-wired cerebrolysin vs. poly (D, L-lactide-coglycolide) nano-particles loaded delivery in Alzheimerâ??s disease brain pathology

Authors: Hari S Sharma, Dafin F Muresanu, Giovanni Tosi, Barbara Ruozi, Flavio Forani, Herbert Mossler, Aruna Sharma

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Nano-delivery of drugs induces better therapeutic effects in preventing neurological diseases and their effects are also prolonged than the parent compounds. Thus, the need of the hour to examine whether drugs tagged with different kinds of nanoparticles may have different effects following their nano-delivery in treating neurological diseases e.g., Alzheimerâ??s disease (AD). AD is mainly characterized by deposition of amyloid Ã?-peptide (ABP) in various brain regains leading to cell and tissue destruction. It is widely believed that breakdown of the blood-brain barrier (BBB) to serum constituents activates a series of abnormal reactions leading to immunological, biochemical and pathological changes culminating in AD. Thus, to reduce the BBB breakdown and induce neuroregeneration or neuro-repair using several neuro-trophic factors in combination could alleviate AD symptoms. Our laboratory is engaged to find out whether cerebrolysin, a multimodal drug (Ever Neuro Pharma, Austria) comprising a well-balanced composition of several neuro-trophic factors and active peptide fragments could induce neuro-protection in animal models of AD. AD like symptoms were induced in rats by chronic infusion of amyloid Ã?-peptide (ABP 1-40) intra-ventricularly (I.C.V) in the left cerebral ventricle (250ng/10 μl) once daily for 4 weeks. Cerebrolysin was delivered in identical fashion using two different modes of nanodelivery. Thus, TiO2 nano-wired delivery of cerebrolysin was compared with identical doses of poly (D, L-lactide-co-glycolide) nanoparticles (PLG-NPs) loaded delivery. Our observations showed marked deposition of ABP and neuronal, glial and myelin pathology in the cerebral cortex, hippocampus and cerebellum. BBB breakdown was evident by enhanced penetration of serum albumin as seen using immunohistochemistry in the identical brain areas showing neuronal loss, gliosis and myelin damage. Interestingly, TiO2 nano-wired delivery of cerebrolysin in a dose of 25μl infused daily 2 weeks after ABP infusion for 1 week remarkably reduced ABP deposition, and brain pathology. However, identical doses of PLG-NPs loaded cerebrolysin were much less effective after ABP infusion. Interestingly, 50 μl dose of PLG-NPs-Cerebrolsyin was sufficient enough to reduce AD pathology. These observations strongly suggest that TiO2 nano-wired delivery of cerebrolysin has superior effects over PLG-NPs loaded delivery in AD. This indicates that mode of nano-drug delivery of the same compounds is crucial in achieving desired results in neurological diseases.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Nanomedicine & Nanotechnology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Nanomedicine & Nanotechnology
  • SubjectNanotechnology
  • BylineArticles whose byline prints “Hari S Sharma”
  • BylineArticles whose byline prints “Dafin F Muresanu”
  • BylineArticles whose byline prints “Giovanni Tosi”
  • BylineArticles whose byline prints “Barbara Ruozi”
  • BylineArticles whose byline prints “Flavio Forani”
  • BylineArticles whose byline prints “Herbert Mossler”
  • BylineArticles whose byline prints “Aruna Sharma”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels